Healthcare Global Enterprises Limited (HCG) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.193x

Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) has a cash flow conversion efficiency ratio of 0.193x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.92 Billion ≈ $20.79 Million USD) by net assets (Rs9.94 Billion ≈ $107.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HCG defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Healthcare Global Enterprises Limited - Cash Flow Conversion Efficiency Trend (2011–2026)

This chart illustrates how Healthcare Global Enterprises Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Healthcare Global Enterprises Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Healthcare Global Enterprises Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Horizon Bancorp
NASDAQ:HBNC
0.030x
Southside Bancshares, Inc.
NYSE:SBSI
0.057x
CBL & Associates Properties Inc
NYSE:CBL
0.204x
Verve Therapeutics Inc
NASDAQ:VERV
-0.059x
Shenzhen Shenbao Industrial Co Ltd
SHE:000019
0.106x
Lintes Technology Co Ltd
TW:6715
-0.004x
Nitratos de Chile SA
SN:NITRATOS
0.085x
Burford Capital Ltd
NYSE:BUR
-0.026x

Annual Cash Flow Conversion Efficiency for Healthcare Global Enterprises Limited (2011–2026)

The table below shows the annual cash flow conversion efficiency of Healthcare Global Enterprises Limited from 2011 to 2026. For the full company profile with market capitalisation and key ratios, see Healthcare Global Enterprises Limited market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs14.10 Billion
≈ $152.51 Million
Rs3.47 Billion
≈ $37.54 Million
0.246x -23.15%
2025-03-31 Rs9.90 Billion
≈ $107.07 Million
Rs3.17 Billion
≈ $34.29 Million
0.320x -2.63%
2024-03-31 Rs8.65 Billion
≈ $93.56 Million
Rs2.85 Billion
≈ $30.78 Million
0.329x +13.67%
2023-03-31 Rs8.69 Billion
≈ $94.02 Million
Rs2.52 Billion
≈ $27.21 Million
0.289x +16.17%
2022-03-31 Rs8.84 Billion
≈ $95.57 Million
Rs2.20 Billion
≈ $23.81 Million
0.249x +47.57%
2021-03-31 Rs7.14 Billion
≈ $77.22 Million
Rs1.21 Billion
≈ $13.03 Million
0.169x -45.55%
2020-03-31 Rs4.20 Billion
≈ $45.40 Million
Rs1.30 Billion
≈ $14.07 Million
0.310x +64.35%
2019-03-31 Rs5.22 Billion
≈ $56.47 Million
Rs985.04 Million
≈ $10.65 Million
0.189x +11.67%
2018-03-31 Rs5.79 Billion
≈ $62.62 Million
Rs978.13 Million
≈ $10.58 Million
0.169x -9.29%
2017-03-31 Rs4.90 Billion
≈ $53.00 Million
Rs912.79 Million
≈ $9.87 Million
0.186x +16.66%
2016-03-31 Rs4.59 Billion
≈ $49.59 Million
Rs731.97 Million
≈ $7.92 Million
0.160x -44.47%
2015-03-31 Rs2.08 Billion
≈ $22.44 Million
Rs596.53 Million
≈ $6.45 Million
0.287x +57.70%
2014-03-31 Rs2.82 Billion
≈ $30.51 Million
Rs514.22 Million
≈ $5.56 Million
0.182x +73.35%
2013-03-31 Rs2.96 Billion
≈ $32.01 Million
Rs311.26 Million
≈ $3.37 Million
0.105x +4206.51%
2012-03-31 Rs2.19 Billion
≈ $23.73 Million
Rs-5.62 Million
≈ $-60.78K
-0.003x -102.04%
2011-03-31 Rs1.76 Billion
≈ $19.08 Million
Rs221.98 Million
≈ $2.40 Million
0.126x --

About Healthcare Global Enterprises Limited

NSE:HCG India Medical Care Facilities
Market Cap
$992.60 Million
Rs91.78 Billion INR
Market Cap Rank
#9094 Global
#439 in India
Share Price
Rs614.75
Change (1 day)
-1.89%
52-Week Range
Rs521.75 - Rs776.30
All Time High
Rs776.30
About

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more